Multiomic analysis of immune-related adverse events (irAEs) in melanoma patients treated with anti-PD1-based immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Dimitriou, F.
Cheng, P. [1 ]
Saltari, A. [1 ]
Staeger, R. [1 ]
Tastanova, A. [1 ]
Levesque, M. [1 ]
Long, G. [3 ]
Becher, B. [2 ]
Dummer, R. [1 ]
机构：
[1] Univ Spital Zurich, Dept Dermatol, Zurich, Switzerland
[2] Univ Zurich, Dept Immunol, Zurich, Switzerland
[3] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
1607
引用
收藏
页码：S275 / S275
页数：1
相关论文
共 50 条
  • [21] Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors
    Pan, Catherina X.
    Liu, Mofei
    Lau, Charles B.
    Lau, William C.
    Kim, Daniel Y.
    Saberi, Shahin A.
    Rowley, Rachael
    Kanwar, Ruhi
    Giobbie-Hurder, Anita
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (04) : 826 - 829
  • [22] Correlation between immune-related adverse events (irAEs) and efficacy in patients with solid tumors treated with immune-checkpoints inhibitors (ICIs).
    Riudavets, Mariona
    Barba, Andres
    Maroto, Pablo
    Sullivan, Ivana Gabriela
    Anguera, Georgia
    Paez, David
    del Carpio, Luis
    Callejo, Ana
    Gonzalez Blanco, Cintia
    Garcia Planellas, Esther
    Castillo, Diego
    Facundo, Carme
    Genua, Idoia
    Martin Lorente, Cristina
    Virgili, Ana
    Sebio, Ana
    Gallego, Oscar
    Lopez-Pousa, Antonio
    Barnadas, Agust
    Majem, Margarita
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Analysis of immune-related adverse events in gastrointestinal malignancy patients treated with immune checkpoint inhibitors
    Niu, Chengu
    Zhu, Kaiwen
    Zhang, Jing
    Joshi, Utsav
    Liu, Hongli
    Zahid, Salman
    Jadhav, Nagesh
    Okolo, Patrick I.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1261 - 1271
  • [24] Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
    Daban, A.
    Gonnin, C.
    Phan, L.
    Saldmann, A.
    Granier, C.
    Lillo-Lelouet, A.
    Le Beller, C.
    Pouchot, J.
    Weiss, L.
    Tartour, E.
    Fabre, E.
    Medioni, J.
    Oudard, S.
    Vano, Y. A.
    Dragon-Durey, M. A.
    Simonaggio, A.
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [25] Association between immune-related adverse events and prognosis in patients treated with immune checkpoint inhibitors in melanoma: A surrogacy analysis
    Euvrard, Romain
    Robert, Marie
    Mainbourg, Sabine
    Dalle, Stephane
    Lega, Jean-Christophe
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (02) : 369 - 379
  • [26] Autoantibodies as potential biomarkers of high grade immune-related adverse events (irAEs) in metastatic melanoma patients treated with check point inhibitors (ICIs)
    Gandhi, A.
    Taylor, J.
    Morici, M.
    Reid, A.
    Meniawy, T.
    Khattak, M. A.
    Millward, M.
    Gray, E. S.
    Zaenker, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S597 - S597
  • [27] Predictors of endocrine immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICI) in routine clinical practice
    Kozhevnikov, Alexander
    Mkrtumyan, Ashot
    Feoktistova, Polina Serrgeevna
    Filonenko, Daria
    Polshina, Natalya
    Volkova, Ekaterina
    Grechukhina, Katerina
    Bykonya, Irina
    Zhukova, Lyudmila
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [28] PD-1 immune checkpoint inhibitors and serious immune-related adverse events
    Baek, Yeon-Hee
    Kang, Eun Joo
    Hong, Soojung
    Park, So-Hee
    Kim, Ju Hwan
    Wong, Ian C.
    Au, Philip C. -M.
    Cheung, Ching-Lung
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 293 - 293
  • [29] Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors
    Teng, Yi-Shan
    Yu, Sebastian
    CURRENT ONCOLOGY, 2023, 30 (07) : 6805 - 6819
  • [30] Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management
    Muntyanu, Anastasiya
    Netchiporouk, Elena
    Gerstein, William
    Gniadecki, Robert
    Litvinov, Ivan V.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2021, 25 (01) : 59 - 76
12345